Today's Hospitalist
MAY 16, 2025
That’s when the health system turned to a company that provides a turnkey SNF-care program. A struggle for enough staffing When the federal government launched the readmission penalty program in 2013, staff with OSF HealthCare knew their readmission rates fueled by bouncebacks from SNFs were running between 18% and 25%.
Annals of Family Medicine
NOVEMBER 20, 2024
Understanding health information seeking behavior is critical in providing effective interventions and improving quality of life for patients, especially for those facing complex health needs. Newly diagnosed cancer patients in rural areas are less likely to rely on structured sources of information, even after adjusting for all covariates.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
DECEMBER 4, 2023
Houck — Separate decisions by federal district courts in Texas and Puerto Rico in the past two months provide cautionary tales for every pharmacy and wholesale distributor dispensing or distributing controlled substances. The government asserted additional allegations that are outside our scope. By Larry K. Zarzamora Press Release.
Common Sense Family Doctor
MARCH 18, 2025
The COVID-19 pandemic and the isolation caused by public health measures to slow its spread exacerbated a mismatch between the need for mental health care and the number of professionals trained to provide that care. Even though stigma prevents many persons with mental health problems from seeking care, there has never been enough go around.
Physician's Weekly
JUNE 24, 2025
Deana Hendrickson, 66, who provides daily care for three young grandsons in Los Angeles, sought an additional MMR shot, though she was vaccinated against measles, mumps, and rubella as a child, in case her immunity to measles had waned. “I’m sort of hectoring,” she acknowledged. The nation’s health secretary, Robert F.
ABIM
MAY 18, 2025
IBD is also increasingly being diagnosed in racial and ethnic minorities, children, and older adults. This burden of the disease is being felt by patients and healthcare providers. Now, in 2025, it’s both validating and heartbreaking to see the rise in IBD diagnoses in Peru. Many IBD patients in the U.S.,
FDA Law Blog
JANUARY 31, 2023
Of course, no patent counsel “worth their salt” would ever WANT to make a statement against their interest that they were incapable of coming up with any possible way to show that this drug’s use in treating a rare condition was indeed “new” and “not obvious”.
Expert insights. Personalized for you.
91 
Let's personalize your content